Publicacions (26) Publicacions de María Laura Gutiérrez Troncoso

2021

  1. Genomic heterogeneity of pancreatic ductal adenocarcinoma and its clinical impact

    Cancers, Vol. 13, Núm. 17

  2. Genomic profiling of sporadic liver metastatic colorectal cancer

    Seminars in Cancer Biology, Vol. 71, pp. 98-108

2020

  1. A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma

    Cancers, Vol. 12, Núm. 6

  2. Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients

    Cancer Drug Resistance, Vol. 3, Núm. 1, pp. 83-97

2018

  1. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy

    Modern Pathology, Vol. 31, Núm. 8, pp. 1318-1331

  2. Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients after Pancreaticoduodenectomy

    Journal of Clinical Gastroenterology, Vol. 52, Núm. 2, pp. e11-e17

  3. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome

    Haematologica, Vol. 103, Núm. 7, pp. 1198-1208

  4. Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia

    Leukemia, Vol. 32, Núm. 12, pp. 2701-2705

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

2016

  1. Genomic characterization of liver metastases from colorectal cancer patients

    Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922

2015

  1. Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas

    Oncotarget, Vol. 6, Núm. 22, pp. 19070-19086

2014

  1. Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcome

    Journal of Molecular Diagnostics, Vol. 16, Núm. 6, pp. 648-659

  2. Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer

    Medicine (United States), Vol. 93, Núm. 26

  3. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer

    Cancer, Vol. 120, Núm. 13, pp. 1948-1959

  4. Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

    Leukemia

  5. Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene

    American Journal of Hematology, Vol. 89, Núm. 3, pp. 288-294

2013

  1. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: A study in highly purified aberrant plasma cells

    Haematologica, Vol. 98, Núm. 2, pp. 279-287

  2. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis

    Leukemia, Vol. 27, Núm. 11, pp. 2149-2156

2012

  1. Prognostic impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas

    PLoS ONE, Vol. 7, Núm. 8

  2. The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome

    PLoS ONE, Vol. 7, Núm. 8